Stay updated on KarXT for Schizophrenia: Long-term Clinical Trial
Sign up to get notified when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.
Latest updates to the KarXT for Schizophrenia: Long-term Clinical Trial page
- Check7 days agoChange DetectedMedlinePlus related topics now omit Schizophrenia and MedlinePlus Genetics. This is a non-critical navigation change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check14 days agoChange DetectedThe page now lists Schizophrenia and MedlinePlus Genetics as related topics, with the revision label updated to v3.3.2 (removing v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedRevision: v3.3.1 was added; Schizophrenia and MedlinePlus Genetics-related topics were removed (and Revision: v3.2.0 was removed). The primary study details remain unchanged.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoved the government funding/operating status notice from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check43 days agoChange DetectedStudy Record Dates now displays results-related timestamps with corresponding dates. This adds publication-tracking metadata without altering core study design, eligibility criteria, or outcomes.SummaryDifference0.2%
- Check64 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Schizophrenia, expanding the page's scope to include genetics-related information on schizophrenia.SummaryDifference0.1%
Stay in the know with updates to KarXT for Schizophrenia: Long-term Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.